EPSTI1 as an immune biomarker predicts the prognosis of patients with stage III colon cancer

OBJECTIVE: The poor prognosis and heterogeneity of stage III colon cancer (CC) suggest the need for more prognostic biomarkers. The tumor microenvironment (TME) plays a crucial role in tumor progression. We aimed to explore novel immune infiltration-associated molecules that serve as potential progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xitao, Cheng, Wei, Zeng, Xingzhi, Dou, Xiaolin, Zhou, Zhongyi, Pei, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623419/
https://www.ncbi.nlm.nih.gov/pubmed/36330510
http://dx.doi.org/10.3389/fimmu.2022.987394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623419/
https://www.ncbi.nlm.nih.gov/pubmed/36330510
http://dx.doi.org/10.3389/fimmu.2022.987394

Ejemplares similares